发明授权
US06222040B1 Selective NPY (Y5) antagonists (tricyclics) 有权
选择性NPY(Y5)拮抗剂(三环)

Selective NPY (Y5) antagonists (tricyclics)
摘要:
This invention is directed to tricyclic compounds which are selective antagonists for NPY (Y5) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.
信息查询
0/0